These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Medical management of hyperlipidemia and the role of probucol. Davignon J Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320 [TBL] [Abstract][Full Text] [Related]
6. Rational drug therapy of the hyperlipoproteinemias, Part II. Blum CB; Levy RI Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266 [No Abstract] [Full Text] [Related]
7. When to treat hyperlipidemia. Kane JP; Malloy MJ Adv Intern Med; 1988; 33():143-63. PubMed ID: 3278503 [No Abstract] [Full Text] [Related]
8. Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Nash DT Postgrad Med; 1983 Apr; 73(4):75-82. PubMed ID: 6572892 [TBL] [Abstract][Full Text] [Related]
9. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. Stein EA; Heimann KW S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650 [TBL] [Abstract][Full Text] [Related]
10. Current pharmacologic treatment of elevated serum cholesterol. Tikkanen MJ; Nikkilä EA Circulation; 1987 Sep; 76(3):529-33. PubMed ID: 3476221 [TBL] [Abstract][Full Text] [Related]
11. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs. Mälkönen M; Muona M; Manninen V Acta Med Scand Suppl; 1982; 668():130-5. PubMed ID: 6963088 [TBL] [Abstract][Full Text] [Related]
12. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601 [No Abstract] [Full Text] [Related]
13. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
14. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674 [No Abstract] [Full Text] [Related]
15. Contemporary recommendations for evaluating and treating hyperlipidemia. Perry RS Clin Pharm; 1986 Feb; 5(2):113-27. PubMed ID: 3514084 [TBL] [Abstract][Full Text] [Related]
16. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042 [No Abstract] [Full Text] [Related]
17. Hypolipidemic drugs. Fleischmajer R Am Fam Physician; 1978 Feb; 17(2):188-90. PubMed ID: 622945 [No Abstract] [Full Text] [Related]
18. Addition to labeling of cholestyramine. FDA Drug Bull; 1985 Apr; 15(1):7-8. PubMed ID: 3858190 [No Abstract] [Full Text] [Related]
19. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med; 1988 Jan; 148(1):36-69. PubMed ID: 3422148 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and management of lipoprotein disorders. Schaefer EJ; Levy RI N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163 [No Abstract] [Full Text] [Related] [Next] [New Search]